Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Morikis

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|April 17, 2012
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validationMeghan L Bellows-Peterson, Ho Ki Fung, Christodoulos A Floudas, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
Scientific Reports|February 26, 2021
SPARC coordinates extracellular matrix remodeling and efficient recruitment to and migration of antigen-specific T cells in the brain following infectionKathryn E McGovern, J Philip Nance, Clément N David, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Frontiers in Molecular Biosciences|April 8, 2021
Role of Electrostatic Hotspots in the Selectivity of Complement Control Proteins Toward Human and Bovine Complement InhibitionYogesh B Narkhede, Avneesh K Gautam, Rohaine V Hsu, et al.
Journal of Medicinal Chemistry|December 11, 2014
New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristicsRonald D Gorham, David L Forest, George A Khoury, et al.
Experimental Eye Research|August 20, 2013
Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell culturesRonald D Gorham, David L Forest, Phanourios Tamamis, et al.
Cell Chemical Biology|March 5, 2019
Characterization, Dynamics, and Mechanism of CXCR4 Antagonists on a Constitutively Active MutantEric M Rosenberg, Reed E S Harrison, Lun Kelvin Tsou, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2015
Endosidin2 targets conserved exocyst complex subunit EXO70 to inhibit exocytosisChunhua Zhang, Michelle Q Brown, Wilhelmina van de Ven, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|April 17, 2012
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validationMeghan L Bellows-Peterson, Ho Ki Fung, Christodoulos A Floudas, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
Scientific Reports|February 26, 2021
SPARC coordinates extracellular matrix remodeling and efficient recruitment to and migration of antigen-specific T cells in the brain following infectionKathryn E McGovern, J Philip Nance, Clément N David, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Frontiers in Molecular Biosciences|April 8, 2021
Role of Electrostatic Hotspots in the Selectivity of Complement Control Proteins Toward Human and Bovine Complement InhibitionYogesh B Narkhede, Avneesh K Gautam, Rohaine V Hsu, et al.
Journal of Medicinal Chemistry|December 11, 2014
New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristicsRonald D Gorham, David L Forest, George A Khoury, et al.
Experimental Eye Research|August 20, 2013
Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell culturesRonald D Gorham, David L Forest, Phanourios Tamamis, et al.
Cell Chemical Biology|March 5, 2019
Characterization, Dynamics, and Mechanism of CXCR4 Antagonists on a Constitutively Active MutantEric M Rosenberg, Reed E S Harrison, Lun Kelvin Tsou, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2015
Endosidin2 targets conserved exocyst complex subunit EXO70 to inhibit exocytosisChunhua Zhang, Michelle Q Brown, Wilhelmina van de Ven, et al.
Pageof 8